Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.48M | 3.41M | 3.21M | 3.21M | 2.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.69M | 3.62M | 3.37M | 3.37M | 2.36M |
| Operating Income | -3.69M | -3.62M | -3.37M | -3.37M | -2.36M |
| Income Before Tax | -4.15M | -3.97M | -3.62M | -3.69M | -2.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.15 | -3.97 | -3.62 | -3.69 | -2.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.15M | -3.97M | -3.62M | -3.69M | -2.61M |
| EBIT | -3.69M | -3.62M | -3.37M | -3.37M | -2.36M |
| EBITDA | -3.66M | -3.59M | -3.35M | -3.34M | -2.33M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 4.35B | 4.29B | 4.24B | 4.20B | 4.17B |
| Average Diluted Shares Outstanding | 4.35B | 4.29B | 4.24B | 4.20B | 4.17B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |